Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector

Gregory P. Bisson, Ian Frank, Robert Gross, Vincent Lo Re, Jordan B. Strom, Xingmei Wang, Mpho Mogorosi, Tendani Gaolathe, Ndwapi Ndwapi, Harvey Friedman, Brian L. Strom, Diana Dickinson

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Abstract

A large number of HIV-infected patients in sub-Saharan Africa pay out-of-pocket for HAART. This analysis from Botswana indicates that higher median out-of-pocket regimen costs to patients for the initial 30 days of HAART are associated with failure to achieve a viral load< 400 copies/ml [US$32; interquartile range (IQR), 20-84 compared with US$22; (IQR, 17-36), P = 0.001]. HAART costs should be minimized as scale-up efforts in sub-Saharan Africa progress.

Original languageEnglish (US)
Pages (from-to)1333-1336
Number of pages4
JournalAIDS
Volume20
Issue number9
DOIs
StatePublished - Jun 2006
Externally publishedYes

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Out-of-pocket costs of HAART limit HIV treatment responses in Botswana's private sector'. Together they form a unique fingerprint.

Cite this